Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather N Reich

Showing results (41-50 of 123) with videos related to

Pageof 13
Sort By:
Kidney International Reports|November 9, 2020
Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA NephropathyRichard A Lafayette, Brad H Rovin, Heather N Reich, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 10, 2008
The impact of sex in primary glomerulonephritisDaniel C Cattran, Heather N Reich, Heather J Beanlands, et al.
Clinical Nephrology|March 27, 2012
Rituximab therapy for Type I membranoproliferative glomerulonephritisJohn J Dillon, Michelle Hladunewich, William E Haley, et al.
Diabetes Care|November 6, 2009
Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot studyDavid Z I Cherney, Vesta Lai, James W Scholey, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 27, 2017
Nephrotic Syndrome With Cancer Immunotherapies: A Report of 2 CasesAbhijat Kitchlu, Warren Fingrut, Carmen Avila-Casado, et al.
Diabetes Care|July 28, 2012
The effect of direct renin inhibition alone and in combination with ACE inhibition on endothelial function, arterial stiffness, and renal function in type 1 diabetesDavid Z I Cherney, James W Scholey, Shan Jiang, et al.
Canadian Journal of Physiology and Pharmacology|December 23, 2011
Systemic hemodynamic function in humans with type 1 diabetes treated with protein kinase Cβ inhibition and renin-angiotensin system blockade: a pilot studyDavid Z I Cherney, Heather N Reich, James W Scholey, et al.
Kidney International|June 7, 2013
Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal diseaseSean J Barbour, Daniel C Cattran, S Joseph Kim, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 10, 2022
Quantifying the benefits of remission duration in focal and segmental glomerulosclerosisArenn Jauhal, Heather N Reich, Michelle Hladunewich, et al.
Kidney International|June 1, 2023
IgA nephropathy: the lectin pathway and implications for targeted therapyJonathan Barratt, Richard A Lafayette, Hong Zhang, et al.
Pageof 13

Showing results (41-50 of 123) with videos related to

Sort By:
Pageof 13
Kidney International Reports|November 9, 2020
Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA NephropathyRichard A Lafayette, Brad H Rovin, Heather N Reich, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 10, 2008
The impact of sex in primary glomerulonephritisDaniel C Cattran, Heather N Reich, Heather J Beanlands, et al.
Clinical Nephrology|March 27, 2012
Rituximab therapy for Type I membranoproliferative glomerulonephritisJohn J Dillon, Michelle Hladunewich, William E Haley, et al.
Diabetes Care|November 6, 2009
Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot studyDavid Z I Cherney, Vesta Lai, James W Scholey, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 27, 2017
Nephrotic Syndrome With Cancer Immunotherapies: A Report of 2 CasesAbhijat Kitchlu, Warren Fingrut, Carmen Avila-Casado, et al.
Diabetes Care|July 28, 2012
The effect of direct renin inhibition alone and in combination with ACE inhibition on endothelial function, arterial stiffness, and renal function in type 1 diabetesDavid Z I Cherney, James W Scholey, Shan Jiang, et al.
Canadian Journal of Physiology and Pharmacology|December 23, 2011
Systemic hemodynamic function in humans with type 1 diabetes treated with protein kinase Cβ inhibition and renin-angiotensin system blockade: a pilot studyDavid Z I Cherney, Heather N Reich, James W Scholey, et al.
Kidney International|June 7, 2013
Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal diseaseSean J Barbour, Daniel C Cattran, S Joseph Kim, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 10, 2022
Quantifying the benefits of remission duration in focal and segmental glomerulosclerosisArenn Jauhal, Heather N Reich, Michelle Hladunewich, et al.
Kidney International|June 1, 2023
IgA nephropathy: the lectin pathway and implications for targeted therapyJonathan Barratt, Richard A Lafayette, Hong Zhang, et al.
Pageof 13